AAOS no longer recommends HA injections for symptomatic osteoarthritis of the knee

AAOS releases revised clinical practice guideline for osteoarthritis of the knee (AAOS press release) Intra-articular hyaluronic acid no longer recommended, while recommended dosage of acetaminophen reduced Rosemont, Ill. - The American Academy of Orthopaedic Surgeons (AAOS) recently released its revised clinical practice guideline (CPG) on the treatment of osteoarthritis of the knee, addressing two key changes. Most of the remaining recommendations provided in the 2009 CPG go unchanged. CPGs are not meant to be stand-alone documents, but rather serve as a point of reference and educational tool for both primary care physicians and orthopaedic surgeons. The original guideline, as well as this revised version, was developed to include only treatments which are less invasive than knee replacement surgery. Osteoarthritis (OA) is a common condition that can affect any joint in the body particularly after years of use. It is also known as "wear and tear" arthritis and most commonly occurs in people who are 65 years of age or older. Some 33 million Americans are affected by osteoarthritis, and it is the leading cause of physical disability. The two primary changes recommended in the 2013...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top